TY - JOUR
T1 - Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders
AU - Keblesh, James
AU - Hu, Dehui
AU - Xiong, Huangui
N1 - Funding Information:
Acknowledgements The authors thank the two anonymous reviewers for their critical criticisms and helpful comments. This work was supported by the NIH grant 2 R01 NS041862.
PY - 2009/3
Y1 - 2009/3
N2 - Human immunodeficiency virus type-1 (HIV-1)-associated dementia (HAD), a severe form of HIV-associated neurocognitive disorders (HAND), describes the cognitive impairments and behavioral disturbances which afflict many HIV-infected individuals. Although the precise mechanism leading to HAD is incompletely understood, it is commonly accepted its progression involves a critical mass of infected and activated mononuclear phagocytes (brain perivascular macrophages and microglia) releasing immune and viral products in the brain. These cellular and viral products induce neuronal dysfunction and injury via various signaling pathways. Emerging evidence indicates voltage-gated potassium (Kv) channels, key regulators of cell excitability and animal behavior (learning and memory), are involved in the pathogenesis of HAD/HAND. Here we survey the literature and find that HAD-related alterations in cellular and viral products can increase neuronal Kv channel activity, leading to neuronal dysfunction and cognitive deficits. Thus, neuronal Kv channels may be a new target in the effort to develop therapies for HAD and perhaps other inflammatory neurodegenerative disorders.
AB - Human immunodeficiency virus type-1 (HIV-1)-associated dementia (HAD), a severe form of HIV-associated neurocognitive disorders (HAND), describes the cognitive impairments and behavioral disturbances which afflict many HIV-infected individuals. Although the precise mechanism leading to HAD is incompletely understood, it is commonly accepted its progression involves a critical mass of infected and activated mononuclear phagocytes (brain perivascular macrophages and microglia) releasing immune and viral products in the brain. These cellular and viral products induce neuronal dysfunction and injury via various signaling pathways. Emerging evidence indicates voltage-gated potassium (Kv) channels, key regulators of cell excitability and animal behavior (learning and memory), are involved in the pathogenesis of HAD/HAND. Here we survey the literature and find that HAD-related alterations in cellular and viral products can increase neuronal Kv channel activity, leading to neuronal dysfunction and cognitive deficits. Thus, neuronal Kv channels may be a new target in the effort to develop therapies for HAD and perhaps other inflammatory neurodegenerative disorders.
KW - Cytokines
KW - HIV-1-associated dementia
KW - Learning and memory
KW - Long-term potentiation
KW - Mononuclear phagocytes
KW - Voltage-gated K channels
UR - http://www.scopus.com/inward/record.url?scp=60549089395&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60549089395&partnerID=8YFLogxK
U2 - 10.1007/s11481-008-9106-6
DO - 10.1007/s11481-008-9106-6
M3 - Review article
C2 - 18459047
AN - SCOPUS:60549089395
SN - 1557-1890
VL - 4
SP - 60
EP - 70
JO - Journal of Neuroimmune Pharmacology
JF - Journal of Neuroimmune Pharmacology
IS - 1
ER -